Nitric oxide synthase activity in human pituitary adenomas
A. Kruse
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorH. Broholm
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorI. Rubin
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorK. Schmidt
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorM. Lauritzen
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorA. Kruse
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorH. Broholm
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorI. Rubin
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorK. Schmidt
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorM. Lauritzen
Departments of 1 Neurosurgery; 2 Pathology, and 4 Clinical Neurophysiology, Glostrup University Hospital, Glostrup; and 3 Institute of Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen, Denmark
Search for more papers by this authorAbstract
Objectives – The purpose of the present study was to examine human pituitary adenomas for nitric oxide synthase (NOS) activity by immunohistochemical and enzymatic methods.
Materials and methods – Adenomatous tissue from 16 patients were obtained during operation and stained immunohistochemically for hormone production and for the three NOS isoenzymes. Cell types that expressed NOS immunoreactivity (IR) were identified, and the NOS isoform was noted. NOS activity was measured enzymatically by the conversion of l-arginine to l-citrulline in tissue samples.
Results – Endothelial cells of pituitary adenomas showed increase of eNOS IR compared with control tissue. The nNOS and iNOS IR were the same in adenomas and controls. There was no correlation between NOS IR and NOS activity measured enzymatically and the endocrine activity of the tumour or other clinical variables.
Conclusion – The observation of increased eNOS IR in endothelial cells of adenomas may suggest that NO plays a role in the regulation of blood flow in pituitary adenomas.
References
- 1 Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991; 351: 714–8.
- 2 Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682–5.
- 3 Forstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isoenzymes. Characterisation, purification, molecular cloning, and functions. Hypertension 1994; 23: 1121–31.
- 4 Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348–52.
- 5 Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Eng J Med 1993; 329: 2002–12.
- 6 Pollock JS, Forstermann U, Mitchell JA et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88: 10480–4.
- 7 Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773–7.
- 8 Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82: 7738–42.
- 9 Xie Q-W, Cho HJ, Calaycay J et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225–8.
- 10 Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988; 27: 8706–11.
- 11 Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65–70.
- 12 Andrade S, Hart I, Piper P. Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 1992; 107: 1092–5.
- 13 Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumours. Cancer Res 1995; 55: 727–30.
- 14 Maeda H, Noguchi Y, Sato K, Akaike T. Enhanced vascular permeability in solid tumour is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 1994; 85: 331–4.
- 15 Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6.
- 16 Moncada S. The l-arginine: nitric oxide pathway. Acta Physiol Scand 1992; 145: 201–27.
- 17 Palner RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988; 333: 664–6.
- 18 Radomski MW, Moncada S. Biological role of nitric oxide in platelet function. In: S Moncada, EA Higgs, JR Berrazueta, eds. Clincal relevance of nitric oxide in the cardiovascular system. Madrid: EDICOMPLET, 1991, 45–56.
- 19 Togashi H, Sakuma I, Yoshioka M et al. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 1992; 262: 343–7.
- 20 Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990; 347: 768–70.
- 21 Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH. Nitric oxide. a physiologic mediator of penile erection. Science 1992; 257: 401–3.
- 22 Dirnagl U, Lindauer U, Villringer A. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neurosci Lett 1993; 149: 43–6.
- 23 Fabricius M, Lauritzen M. Examination of the role of nitric oxide for the hypercapnic rise of cerebral blood flow in rats. Am J Physiol 1994; 266: H1457–64.
- 24 Faraci FM, Brian JE Jr. Nitric oxide and the cerebral circulation. Stroke 1994; 25: 692–703.
- 25 Garthwaite J. Glutamate, nitric oxide and cell–cell signalling in the nervous system. Trends Neurosci 1991; 14: 60–7.
- 26 Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 1988; 336: 385–8.
- 27 Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991; 349: 326–8.
- 28 Wang Q, Paulson OB, Lassen NA. Effect of nitric oxide blockade by NG-nitro-l-arginine on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab 1992; 12: 947–53.
- 29 Ceccatelli S, Hulting A, Zhang X, Gustafsson L, Villar M, Høkfeldt T. Nitric oxide synthase in the rat anterior pituitary gland and the role of nitric oxide in regulation of luteinizing hormone secretion. Proc Natl Acad Sci, USA 1993; 90: 11192–6.
- 30 Ceccatelli S, Lundberg S, Fahrenkrug J, Bredt DS, Snyder SH, Hokfeldt T. Evidence for involvement of nitric oxide in the regulation of hypothalamic portal blood flow. Neuroscience 1992; 51: 769–72.
- 31 Duvilanski BH, Zambruno C, Seilicovich A et al. Role of nitric oxide in control of prolactin release by the adenohypophysis. Proc Natl Acad Sci, USA 1995; 92: 170–4.
- 32 Kovach AG, Szabo C, Benyo Z, Csaki C, Greenberg JH, Reivich M. Effects of NG-nitro-l-arginine and l-arginine on regional cerebral blood flow in the cat. J Physiol Lond 1992; 449: 183–96.
- 33 Ueta Y, Levy A, Powells MP et al. Neuronal nitric oxide synthase gene expression in human pituitary tumours: a possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression. Clin Endocrinol 1998; 49: 29–38.
- 34 Fabricius M, Rubin I, Bundgaard M, Lauritzen M. NOS activity in the brain and endothelium: relation to hypercapnic rise of cerebral blood flow in rats. Am J Physiol 1996; 271: H2035–44.
- 35 Lundin P, Pedersen F. The volume of pituitary macroadenomas: assessment with MR imaging. J Comput Assist Tomogr 1992; 16: 519–28.
- 36 Kato M. Involvement of nitric oxide in growth hormone (GH)-releasing hormone GH secretion in rat pituitary cells. Endocrinology 1992; 131: 2133–8.
- 37 McCann SM. The role of nitric oxide at hypothalamic and pituitary levels to alter the release of pituitary hormones: an invited commentary. Eur J Endocrinol 1996; 135: 533–4.
- 38 Lloyd RV, Jin L, Qian X, Zhang S, Scheithauer BW. Nitric oxide in the human pituitary gland. Am J Pathol 1995; 146: 86–94.
- 39 Vanhatalo S, Soinila S. Nitric oxide synthase in the hypothalamo-pituitary pathways. J Chem Neuroanat 1995; 8: 165–73.
- 40 Kruse A, Astrup J, Cold GE, Hansen HH. Pressure and blood flow in pituitary adenomas measured during transsphenoidal surgery. Br J Neurosurgery 1992; 6: 333–42.
- 41 Lees PD, Richards HK, Perry S et al. Changing pattern of pituitary perfusion with development of experimental anterior pituitary tumour. J Neurol Neurosurg Psychiat 1986; 49: 469–70.
- 42 Buttery L, Springall D, Andrade S. Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J Pathol 1993; 171: 311–9.
- 43 Wang Y, Newton DC, Marsden PA, Neuronal NOS: genestructure, mRNA diversity, and functional relevance. Crit Rev Neurobiol 1999; 13: 21–43.
